oral formulation
Showing 51 - 75 of >10,000
Healthy Volunteers, Type 2 Diabetes Trial in Berlin (Oral semaglutide)
Completed
- Healthy Volunteers
- Type 2 Diabetes
- Oral semaglutide
-
Berlin, GermanyNovo Nordisk Investigational Site
Sep 27, 2021
Bioavailability Trial in New Haven (PF-07321332/ritonavir, PF-07321332)
Completed
- Bioavailability
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 28, 2022
Healthy Volunteers Trial in Nottingham (Oral solution, [14C]BMS-986177 Solution for Infusion, BMS-986177 Spray-dried Dispersion
Completed
- Healthy Volunteers
- Oral solution
- +2 more
-
Nottingham, United KingdomLocal Institution
Nov 11, 2021
Acute Pain Trial in Worldwide (Paracetamol Uniflash 125mg, Panadol 500 MG Oral Tablet X1, Panadol 500 MG Oral Tablet X2)
Completed
- Acute Pain
- Paracetamol Uniflash 125mg
- +3 more
-
Bordeaux, France
- +19 more
Nov 10, 2022
Geographic Atrophy, Age-Related Macular Degeneration Trial in Barcelona (postbiotics (IGENH35.3A), vitamins (AREDS formulation
Active, not recruiting
- Geographic Atrophy
- Age-Related Macular Degeneration
- postbiotics (IGENH35.3A)
- vitamins (AREDS formulation and recommended daily dose)
-
Barcelona, SpainInstitut de la MÃ cula
Jun 18, 2022
Healthy Volunteers Trial in Madison (Apremilast Tablet, Apremilast Oral Suspension)
Completed
- Healthy Volunteers
- Apremilast Tablet
- Apremilast Oral Suspension
-
Madison, WisconsinCovance Clinical Research Unit Inc
Jul 14, 2021
Healthy Trial in Nottingham (BI 894416 - Formulation A2, BI 894416 - Formulation C2, BI 894416 - Formulation D2)
Terminated
- Healthy
- BI 894416 - Formulation A2
- +4 more
-
Nottingham, United KingdomQuotient Sciences
Nov 2, 2021
Ocular Hypertension Trial in Australia (FM101 tablet, FM101 oral solution, Placebo)
Recruiting
- Ocular Hypertension
- FM101 tablet
- +4 more
-
Bella Vista, New South Wales, Australia
- +4 more
Jul 18, 2022
Healthy Trial in Rennes (GLPG3970 oral solution, GLPG3970 tablet)
Completed
- Healthy
- GLPG3970 oral solution
- GLPG3970 tablet
-
Rennes, FranceBiotral Rennes
Mar 24, 2021
Eosinophilic Esophagitis Trial in United States (APT-1011, Placebo oral tablet)
Recruiting
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Colorado Springs, Colorado
- +4 more
Jan 4, 2023
Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Indianapolis, Indiana
- +2 more
Nov 13, 2022
Gastro Esophageal Reflux Trial in Siegen, Hannover (Hyaluronic acid with chondroitin sulphate and magnesium trisilicate, 1100 mg
Recruiting
- Gastro Esophageal Reflux
- Hyaluronic acid with chondroitin sulphate and magnesium trisilicate, 1100 mg melt in mouth tablet
- Placebo 1100 mg, identically-looking melt in mouth tablet
-
Siegen, Nordrhein-Westfalen, Germany
- +1 more
Mar 16, 2021
Healthy Volunteers Trial in Nottingham (Part 1: Belumosudil 40 mg/mL Sequence ABFCED, Part 1: Belumosudil 40 mg/mL Sequence
Completed
- Healthy Volunteers
- Part 1: Belumosudil 40 mg/mL Sequence ABFCED
- +11 more
-
Nottingham, England, United KingdomQuotient Sciences
May 10, 2022
Solid Tumor, Adult, Impaired Liver Function Trial in Amsterdam (ModraDoc006/r)
Withdrawn
- Solid Tumor, Adult
- Impaired Liver Function
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek
Oct 18, 2021
Solid Tumours Trial in Worldwide (drug, procedure, other)
Completed
- Solid Tumours
- Olaparib tablets
- +3 more
-
Brussels, Belgium
- +11 more
Mar 29, 2022
United Sates That Looks at Safety and Effectiveness of Pradaxa
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Aug 1, 2023
Dry Mouth, Xerostomia, Type 2 Diabetics Trial in Saint Louis (HA formulation Oral Spray, Placebo)
Completed
- Dry Mouth
- +2 more
- HA formulation Oral Spray
- Placebo
-
Saint Louis, MissouriDivision of Endocrinology and Metabolism, Saint Louis University
Aug 9, 2021
Anesthesia, Local Trial in Alexandria (Oral premedication)
Recruiting
- Anesthesia, Local
- Oral premedication
-
Alexandria, Egypt
- +1 more
Aug 2, 2021
HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)
Recruiting
- HIV Infections
- Cabotegravir sodium (Oral Lead In)
- +6 more
-
Orlando, Florida
- +4 more
Mar 29, 2022
Healthy Trial in Neu-Ulm (Cesol (Test), Biltricide (Reference))
Completed
- Healthy
- Cesol (Test)
- Biltricide (Reference)
-
Neu-Ulm, GermanyNuvisan GmbH
Jul 20, 2021
Nonalcoholic Steatohepatitis (NASH) Trial in United States (LPCN 1144 Formulation A, LPCN 1144 Formulation B, Placebo)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- LPCN 1144 Formulation A
- +2 more
-
El Cajon, California
- +18 more
Aug 1, 2022